{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:22:09Z","timestamp":1793697729476,"version":"4.5.1"},"reference-count":48,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Controlling myopia progression is of interest worldwide. Low-dose atropine eye drops have slowed progression in children in East Asia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare atropine, 0.01%, eye drops with placebo for slowing myopia progression in US children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This was a randomized placebo-controlled, double-masked, clinical trial conducted from June 2018 to September 2022. Children aged 5 to 12 years were recruited from 12 community- and institution-based practices in the US. Participating children had low to moderate bilateral myopia (\u22121.00 diopters [D] to \u22126.00 D spherical equivalent refractive error [SER]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Eligible children were randomly assigned 2:1 to 1 eye drop of atropine, 0.01%, nightly or 1 drop of placebo. Treatment was for 24 months followed by 6 months of observation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome and Measures<\/jats:title>\n                    <jats:p>Automated cycloplegic refraction was performed by masked examiners. The primary outcome was change in SER (mean of both eyes) from baseline to 24 months (receiving treatment); other outcomes included change in SER from baseline to 30 months (not receiving treatment) and change in axial length at both time points. Differences were calculated as atropine minus placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 187 children (mean [SD] age, 10.1 [1.8] years; age range, 5.1-12.9 years; 101 female [54%]; 34 Black [18%], 20 East Asian [11%], 30 Hispanic or Latino [16%], 11 multiracial [6%], 6 West\/South Asian [3%], 86 White [46%]) were included in the study. A total of 125 children (67%) received atropine, 0.01%, and 62 children (33%) received placebo. Follow-up was completed at 24 months by 119 of 125 children (95%) in the atropine group and 58 of 62 children (94%) in the placebo group. At 30 months, follow-up was completed by 118 of 125 children (94%) in the atropine group and 57 of 62 children (92%) in the placebo group. At the 24-month primary outcome visit, the adjusted mean (95% CI) change in SER from baseline was \u22120.82 (\u22120.96 to \u22120.68) D and \u22120.80 (\u22120.98 to \u22120.62) D in the atropine and placebo groups, respectively (adjusted difference\u2009=\u2009\u22120.02 D; 95% CI, \u22120.19 to +0.15 D;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.83). At 30 months (6 months not receiving treatment), the adjusted difference in mean SER change from baseline was \u22120.04 D (95% CI, \u22120.25 to +0.17 D). Adjusted mean (95% CI) changes in axial length from baseline to 24 months were 0.44 (0.39-0.50) mm and 0.45 (0.37-0.52) mm in the atropine and placebo groups, respectively (adjusted difference = \u22120.002 mm; 95% CI, \u22120.106 to 0.102 mm). Adjusted difference in mean axial elongation from baseline to 30 months was +0.009 mm (95% CI, \u22120.115 to 0.134 mm).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this randomized clinical trial of school-aged children in the US with low to moderate myopia, atropine, 0.01%, eye drops administered nightly when compared with placebo did not slow myopia progression or axial elongation. These results do not support use of atropine, 0.01%, eye drops to slow myopia progression or axial elongation in US children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03334253\">NCT03334253<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2023.2855","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T11:07:08Z","timestamp":1689246428000},"page":"756","source":"Crossref","is-referenced-by-count":137,"title":["Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control"],"prefix":"10.1001","volume":"141","author":[{"given":"Michael X.","family":"Repka","sequence":"first","affiliation":[{"name":"Wilmer Eye Institute, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine K.","family":"Weise","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle L.","family":"Chandler","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wu","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Michele","family":"Melia","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth E.","family":"Manny","sequence":"additional","affiliation":[{"name":"University of Houston College of Optometry, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori Ann F.","family":"Kehler","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine O.","family":"Jordan","sequence":"additional","affiliation":[{"name":"Pediatric Ophthalmology Associates, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Raghuram","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison I.","family":"Summers","sequence":"additional","affiliation":[{"name":"Casey Eye Institute, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Lee","sequence":"additional","affiliation":[{"name":"St Luke\u2019s Health System, Boise, Idaho"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Petersen","sequence":"additional","affiliation":[{"name":"Rocky Mountain Eye Care Associates, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Erzurum","sequence":"additional","affiliation":[{"name":"Eye Care Associates Inc, Poland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Pang","sequence":"additional","affiliation":[{"name":"Illinois College of Optometry, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe D.","family":"Lenhart","sequence":"additional","affiliation":[{"name":"Emory Eye Center, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Ticho","sequence":"additional","affiliation":[{"name":"Ticho Eye Associates, Chicago Ridge, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy W.","family":"Beck","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, Florida"},{"name":"Deputy Editor, JAMA Ophthalmology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond T.","family":"Kraker","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Holmes","sequence":"additional","affiliation":[{"name":"University of Arizona-Tucson, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Cotter","sequence":"additional","affiliation":[{"name":"Southern California College of Optometry at Marshall B. Ketchum University, Fullerton"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Pediatric Eye Disease Investigator Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise D.","family":"Alexopoulous","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Allen","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Anderson","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell S.","family":"Austin","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane C.","family":"Black","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Boyle","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant Andrew","family":"Casey","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moriah Adine","family":"Chandler","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Chinn","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Clausius","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth J,","family":"Colon","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney L.","family":"Conner","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda T.","family":"Curtis","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Dinani","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quayleen","family":"Donahue","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Dubois","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Evans","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke P.","family":"Fimbel","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie Kay","family":"Fowler","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Golden","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth G.","family":"Harper","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Henderson","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieu-Hong","family":"Ho","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Hoepner","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine B.","family":"Hopkins","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashli S.","family":"Jenks","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Kaplon","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabana","family":"Khan","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra A.","family":"Koutnik","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie F.","family":"Kuo","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessy","family":"Lee","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel M.","family":"Martinez","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia M.","family":"Marusic","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Lou","family":"McGregor","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Ryan","family":"McMurtrey","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn B.","family":"Miller","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti L.","family":"Mokka","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer","family":"Montejo","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"Morrell","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse","family":"Nylin","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly C.","family":"Odom","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillaine","family":"Ortiz","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha A.","family":"Parra","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle J.","family":"Perkins","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry W.","family":"Plum","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen Fiona","family":"Redenbo","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne L.","family":"Robinson","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Stutz","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desirae R.","family":"Sutherland","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea X.","family":"Teodorescu","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori L.","family":"Torgensen","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David O.","family":"Toro","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip B.","family":"Turner","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie C.","family":"Weil","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily K.","family":"Wiecek","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsyn S.","family":"Wilkins","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria C.","family":"Woodard","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Woodruff","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizi","family":"Yin","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika L.","family":"Yumang","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Yamada","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha S.","family":"Ekdawi","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Leske","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Wallace","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie L.","family":"Christian","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Glaser","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen E.","family":"Birch","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Chen","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Christiansen","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura B.","family":"Enyedi","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald F.","family":"Everett","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon F.","family":"Freedman","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William V.","family":"Good","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin C.","family":"Jenewein","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"London","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian M.","family":"Manh","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Morrison","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy L.","family":"Pineles","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hantamalala","family":"Ralay Ranaivo","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawna L.","family":"Roberts","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Ruark","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonita R.","family":"Schweinler","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne L.","family":"Silver","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donny W.","family":"Suh","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"Verderber","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Diener-West","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Baker","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Davis","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary D.","family":"Higgins","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Poff","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Saunders","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Tychsen","sequence":"additional","affiliation":[{"name":"for the Pediatric Eye Disease Investigator Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7","key":"eoi230037r1","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.ophtha.2015.03.018","article-title":"Increasing prevalence of myopia in Europe and the impact of education.","volume":"122","author":"Williams","year":"2015","journal-title":"Ophthalmology"},{"issue":"12","key":"eoi230037r2","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/archophthalmol.2009.303","article-title":"Increased prevalence of myopia in the US between 1971-1972 and 1999-2004.","volume":"127","author":"Vitale","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"eoi230037r3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050.","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"issue":"10","key":"eoi230037r5","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1001\/archophthalmol.2012.1449","article-title":"New cases of myopia in children.","volume":"130","author":"Kleinstein","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"13","key":"eoi230037r6","doi-asserted-by":"publisher","first-page":"7871","DOI":"10.1167\/iovs.13-12403","article-title":"Myopia stabilization and associated factors among participants in the Correction of Myopia Evaluation Trial (COMET).","volume":"54","author":"COMET Group","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"eoi230037r7","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.ophtha.2021.04.032","article-title":"The risks and benefits of myopia control.","volume":"128","author":"Bullimore","year":"2021","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi230037r8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/OPX.0000000000001367","article-title":"Myopia control: why each diopter matters.","volume":"96","author":"Bullimore","year":"2019","journal-title":"Optom Vis Sci"},{"issue":"2","key":"eoi230037r9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ajo.2013.09.020","article-title":"Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%.","volume":"157","author":"Chia","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"eoi230037r10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops.","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi230037r11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/jop.1997.13.61","article-title":"The effectiveness of 0.5% atropine in controlling high myopia in children.","volume":"13","author":"Chou","year":"1997","journal-title":"J Ocul Pharmacol Ther"},{"issue":"12","key":"eoi230037r12","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia.","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"issue":"9","key":"eoi230037r13","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/ceo.v50.9","article-title":"Low-concentration atropine eye drops for myopia control in a multi-racial cohort of Australian children: a randomised clinical trial.","volume":"50","author":"Lee","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"eoi230037r14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1089\/jop.1999.15.85","article-title":"Effects of different concentrations of atropine on controlling myopia in myopic children.","volume":"15","author":"Shih","year":"1999","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"eoi230037r15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1089\/jop.2011.0017","article-title":"Atropine in ameliorating the progression of myopia in children with mild to moderate myopia: a meta-analysis of controlled clinical trials.","volume":"27","author":"Song","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"eoi230037r16","first-page":"203","article-title":"Atropine and bifocals can slow the progression of myopia in children.","volume":"16","author":"Syniuta","year":"2001","journal-title":"Binocul Vis Strabismus Q"},{"issue":"7","key":"eoi230037r17","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","article-title":"Two-year clinical trial of the Low-Concentration Atropine for Myopia Progression (LAMP) study: phase 2 report.","volume":"127","author":"Yam","year":"2020","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi230037r18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi230037r19","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1001\/jamaophthalmol.2017.1091","article-title":"Efficacy and adverse effects of atropine in childhood myopia: a meta-analysis.","volume":"135","author":"Gong","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"eoi230037r20","doi-asserted-by":"publisher","first-page":"7380","DOI":"10.1038\/s41598-022-10978-3","article-title":"Characteristics of responders to atropine 0.01% as treatment in Asian myopic children.","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"eoi230037r21","article-title":"Interventions to slow progression of myopia in children.","volume":"1","author":"Walline","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"eoi230037r22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/OPX.0000000000001410","article-title":"A 3-year randomized clinical trial of MiSight lenses for myopia control.","volume":"96","author":"Chamberlain","year":"2019","journal-title":"Optom Vis Sci"},{"issue":"5","key":"eoi230037r23","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00417-018-3906-z","article-title":"MiSight Assessment Study Spain (MASS): a 2-year randomized clinical trial.","volume":"256","author":"Ruiz-Pomeda","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"eoi230037r24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jama.2020.10834","article-title":"Effect of high add power, medium add power, or single-vision contact lenses on myopia progression in children: the BLINK randomized clinical trial.","volume":"324","author":"Walline","year":"2020","journal-title":"JAMA"},{"issue":"11","key":"eoi230037r25","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1167\/iovs.12-10565","article-title":"Retardation of Myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial.","volume":"53","author":"Cho","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"eoi230037r26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124535","article-title":"Orthokeratology to control myopia progression: a meta-analysis.","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"key":"eoi230037r27","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2021-321005","article-title":"Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS).","author":"Rappon","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"eoi230037r28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jamaophthalmol.2022.0401","article-title":"Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial.","volume":"140","author":"Bao","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"eoi230037r29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","article-title":"Defocus Inc Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial.","volume":"104","author":"Lam","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"eoi230037r30","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jama.2015.10803","article-title":"Effect of time spent outdoors at school on the development of myopia among children in china: a randomized clinical trial.","volume":"314","author":"He","year":"2015","journal-title":"JAMA"},{"issue":"5","key":"eoi230037r31","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ophtha.2012.11.009","article-title":"Outdoor activity during class recess reduces myopia onset and progression in school children.","volume":"120","author":"Wu","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"eoi230037r32","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.ophtha.2017.12.011","article-title":"Myopia prevention and outdoor light intensity in a school-based cluster randomized trial.","volume":"125","author":"Wu","year":"2018","journal-title":"Ophthalmology"},{"issue":"5","key":"eoi230037r33","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/opo.v41.5","article-title":"Amber light treatment produces hyperopia in tree shrews.","volume":"41","author":"Khanal","year":"2021","journal-title":"Ophthalmic Physiol Opt"},{"issue":"5","key":"eoi230037r34","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ophtha.2021.11.023","article-title":"Effect of repeated low-level red-light therapy for myopia control in children: a multicenter randomized controlled trial.","volume":"129","author":"Jiang","year":"2022","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi230037r35","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jama.2022.24162","article-title":"Effect of low-concentration atropine eye drops vs placebo on myopia incidence in children: the LAMP2 randomized clinical trial.","volume":"329","author":"Yam","year":"2023","journal-title":"JAMA"},{"issue":"12","key":"eoi230037r36","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.ophtha.2017.05.032","article-title":"Atropine for the prevention of myopia progression in children: a report by the American Academy of Ophthalmology.","volume":"124","author":"Pineles","year":"2017","journal-title":"Ophthalmology"},{"issue":"12","key":"eoi230037r37","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s00417-018-4078-6","article-title":"Current trends among pediatric ophthalmologists to decrease myopia progression-an international perspective.","volume":"256","author":"Zloto","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"eoi230037r38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-Concentration Atropine for Myopia Progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control.","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"issue":"11","key":"eoi230037r39","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","article-title":"Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children: a randomized clinical trial.","volume":"138","author":"Wei","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"eoi230037r40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10384-021-00822-y","article-title":"Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study.","volume":"65","author":"Hieda","year":"2021","journal-title":"Jpn J Ophthalmol"},{"issue":"9","key":"eoi230037r41","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.ophtha.2021.01.026","article-title":"Atropine for the treatment of childhood myopia in India: multicentric randomized trial.","volume":"128","author":"Saxena","year":"2021","journal-title":"Ophthalmology"},{"key":"eoi230037r42","doi-asserted-by":"publisher","first-page":"i5239","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials.","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"issue":"22","key":"eoi230037r43","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1016\/S0042-6989(02)00258-4","article-title":"Undercorrection of myopia enhances rather than inhibits myopia progression.","volume":"42","author":"Chung","year":"2002","journal-title":"Vision Res"},{"issue":"5","key":"eoi230037r44","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1444-0938.2006.00055.x","article-title":"The possible effect of undercorrection on myopic progression in children.","volume":"89","author":"Adler","year":"2006","journal-title":"Clin Exp Optom"},{"issue":"3","key":"eoi230037r45","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","article-title":"Adaptive linear step-up procedures that control the false discovery rate.","volume":"93","author":"Benjamini","year":"2006","journal-title":"Biometrika"},{"issue":"10","key":"eoi230037r46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1167\/iovs.62.10.36","article-title":"Myopia progression as a function of sex, age, and ethnicity.","volume":"62","author":"Jones-Jordan","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"eoi230037r47","first-page":"257","article-title":"Influence of age and race on axial elongation in myopic children.","volume":"63","author":"Shamp","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"eoi230037r48","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1167\/iovs.02-0816","article-title":"A randomized clinical trial of progressive addition lenses vs single vision lenses on the progression of myopia in children.","volume":"44","author":"Gwiazda","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"eoi230037r4","unstructured":"National Eye Institute. Nearsightedness (myopia) tables. Accessed June 2, 2022. https:\/\/www.nei.nih.gov\/learn-about-eye-health\/eye-health-data-and-statistics\/nearsightedness-myopia-data-and-statistics\/nearsightedness-myopia-tables"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2807117\/jamaophthalmology_repka_2023_oi_230037_1691537623.01872.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T11:17:26Z","timestamp":1692271046000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2807117"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.2855","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}